ARTELO BIOSCIENCES, INC.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-2.4M | $-2.5M | $-3.1M | $-2.4M | $-1.6M | $-2.2M | $-3.3M | $-2.3M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $195.0K | $213.0K | $219.0K | $222.0K | $225.0K | $354.0K | $608.0K | $607.0K |
| Net Cash from Operating Activities | $-2.1M | $-2.9M | $-2.6M | $-1.8M | $-1.6M | $-2.2M | $-2.3M | $-1.7M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $1.8M | $1.3M | $2.7M | $-1.8M | $399.0K | $2.2M | $1.8M | $-3.1M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $0 | $55.0K | $32.0K | $535.0K | $0 | $0 | $134.0K | $0 |
| Net Change in Cash | $-314.0K | $-1.6M | $176.0K | $-3.1M | $-1.2M | $28.0K | $-248.0K | $-5.0M |
| Free Cash Flow | — | — | — | — | — | — | — | — |